Hybrid proteins of active-site serine β-lactamase
AssigneeUniversite De Liege
InventorsFabrizio Giannotta, Patrice Filee, Moreno Galleni, Jean-Marie Frere, Bernard Joris, Alain Brans, Nadia Ruth
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversite De Liege
InventorsFabrizio Giannotta, Patrice Filee, Moreno Galleni, Jean-Marie Frere, Bernard Joris, Alain Brans, Nadia Ruth
Estimating the term…
The present invention refers to a recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine β-lactamase protein, wherein the β-lactamase protein is bearing at least one heterologous sequence, wherein in that the hybrid protein is having two functions, the first function is associated with the β-lactamase portion and the second function is associated with the heterologous sequence having a biological function which is different from the first function.
A recombinant nucleotide sequence which codes upon expression a bifunctional hybrid active-site serine β-lactamase protein, wherein the β-lactamase protein is a class A, C or D β-lactamase protein that bears at least one heterologous sequence in a region located between two neighboring alpha helices of the β-lactamase sequence, wherein the region is selected from the group consisting of:
A recombinant nucleotide sequence which codes upon expression a bifunctional hybrid class A β-lactamase protein, wherein the class A β-lactamase protein bears at least one heterologous sequence in a region located between two neighboring alpha helices of the β-lactamase sequence, wherein the region is selected from the group consisting of:
Dependencies are inferred from the claim text.